Hepatocellular adenoma pathophysiology

Jump to navigation Jump to search
https://https://www.youtube.com/watch?v=4f4H3xBhF9I%7C350}}

Hepatocellular adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatocellular adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular adenoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular adenoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular adenoma pathophysiology

CDC on Hepatocellular adenoma pathophysiology

Hepatocellular adenoma pathophysiology in the news

Blogs on Hepatocellular adenoma pathophysiology

Directions to Hospitals Treating Hepatocellular adenoma

Risk calculators and risk factors for Hepatocellular adenoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

On gross pathology, well circumscribed, nonlobulated, smooth and soft, and white to yellow to brown lesions are findings of a solitary hepatocellular adenoma.[1][2] On microscopic histopathological analysis, cords of hepatocytes that have a high glycogen and fat content, lack of normal hepatic parenchymal architecture, and an absence of portal tracts and hepatic veins are characteristic findings of hepatocellular adenoma.[1]

Pathophysiology

  • The exact pathogenesis of hepatocellular adenoma is still unknown, however, its association with oral contraceptive use is well established.
  • In 1973, Baum et al first described the causal association of hepatocellular adenoma with oral contraceptive use.
  • In 1979, Rooks et al reported the relationship with oral contraceptive use to be dose and duration dependent and is highest in women over 30 years of age after using oral contraceptive for more than 24 months.
  • Hepatocellular adenoma has also been associated with long term use of anabolic androgenic steroids and glycogen storage diseases.
  • Other rare causal associations include; familial adenomatous polyposis, maturity onset diabetes of young, obesity, metabolic syndrome and vascular disorders like portal vein agenesis, budd chiari syndrome and hereditary hemmorhagic telangeictasia.

Genetics

The pathogenesis of hepatocellular adenoma usually involves the Wnt signalling pathway.

Gross Pathology

  • On gross pathological appearance, the hepatocellular adenoma is a solitary or multiple, un encapsulated and well demarcated mass lesion, which can occasionally be pedunculated or encapsulated, which can also form multiple masses.[1][2]
  • The mass has a soft and fleshy consistency and size ranges from 1 to 30 cm.
  • The cut surface may be solid tan or yellow depending upon the presence or absence of steatosis.
  • The intratumoral hemorrhage can give rise to a soft, necrotic, red brown lesion.
  • Tumor hepatocytes have cytoplasm that may be normal, clear (glycogen rich), steatotic or contain pigment in the lysosomes. Nuclear atypia and mitosis are unusual but may be seen in specific variants.

Microscopic Pathology

  • The microscopic features of hepatocellular adenoma include benign hepatocytes arranged in mildly thickened cell plates, with a preserved reticulin network and thin walled arteries.[1]
  • The arteries and arterioles are not accompanied by other portal tract elements such as bile ducts, portal veins or fibroconnective tissue.
  • Other variable features include; the presence of steatosis, inflammatory cell infiltrates, dystrophic blood vessels, ductular reaction, sinusoidal dilatation, hemorhage and peliosis.

References

  1. 1.0 1.1 1.2 1.3 Barthelmes L, Tait IS (2005). "Liver cell adenoma and liver cell adenomatosis". HPB (Oxford). 7 (3): 186–96. doi:10.1080/13651820510028954. PMC 2023950. PMID 18333188.
  2. 2.0 2.1 Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A (2001). "Hepatic adenomas: imaging and pathologic findings". Radiographics. 21 (4): 877–92, discussion 892-4. doi:10.1148/radiographics.21.4.g01jl04877. PMID 11452062.
  3. Hepatic adenoma. Librepathology (2015). http://librepathology.org/wiki/index.php/File:Hepatic_adenoma_low_mag.jpg Accessed on November 3, 2015
  4. Hepatic adenoma. Librepathology (2015). http://librepathology.org/wiki/index.php/File:Hepatic_adenoma_high_mag.jpg Accessed on November 7, 2015


Template:WikiDoc Sources